Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 212

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study

Open access
Lewnard, Joseph A, Liu, Vincent X, Jackson, Michael L, Schmidt, Mark A, Jewell, Britta L, Flores, Jean P, Jentz, Chris, Northrup, Graham R, Mahmud, Ayesha, Reingold, Arthur L, Petersen, Maya, Jewell, Nicholas P, Young, Scott, Bellows, Jim · 2020 · BMJ

Published version of a preprint

Abstract

Objective: To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States. Design: Prospective cohort study. Setting: Kaiser Permanente integrated healthcare delivery systems serving populations in northern California, southern California, and Washington state. Participants: 1840 people with a first acute hospital admission for confirmed covid-19 by 22 April 2020, among 9 596 321 healthcare plan enrollees. Analyses of hospital length of stay and clinical outcomes included 1328 people admitted by 9 April 2020 (534 in northern California, 711 in southern California, and 83 in Washington). Main outcome measures: Cumulative incidence of first acute hospital admission for confirmed covid-19, and subsequent probabilities of admission to an intensive care unit (ICU) and mortality, as well as duration of hospital stay and ICU stay. The effective reproduction number ( R E ) describing transmission dynamics was estimated for each region. Results: As of 22 April 2020, cumulative incidences of a first acute hospital admission for covid-19 were 15.6 per 100 000 cohort members in northern California, 23.3 per 100 000 in southern California, and 14.7 per 100 000 in Washington. Accounting for censoring of incomplete hospital stays among those admitted by 9 April 2020, the estimated median duration of stay among survivors was 9.3 days (with 95% staying 0.8 to 32.9 days) and among non-survivors was 12.7 days (1.6 to 37.7 days). The censoring adjusted probability of ICU admission for male patients was 48.5% (95% confidence interval 41.8% to 56.3%) and for female patients was 32.0% (26.6% to 38.4%). For patients requiring critical care, the median duration of ICU stay was 10.6 days (with 95% staying 1.3 to 30.8 days). The censoring adjusted case fatality ratio was 23.5% (95% confidence interval 19.6% to 28.2%) among male inpatients and 14.9% (11.8% to 18.6%) among female inpatients; mortality risk increased with age for both male and female patients. Reductions in R E were identified over the study period within each region. Conclusions: Among residents of California and Washington state enrolled in Kaiser Permanente healthcare plans who were admitted to hospital with covid-19, the probabilities of ICU admission, of long hospital stay, and of mortality were identified to be high. Incidence rates of new hospital admissions have stabilized or declined in conjunction with implementation of social distancing interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.m1923

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 31

  1. 10.1136/bmj.m1090 · DOI · Paper page
  2. 10.1016/j.cmi.2020.02.005 · DOI
  3. 10.25561/77482 · doi:10.25561/77482 · Paper page
  4. 10.1016/S0140-6736(20)30743-1 · doi:10.1016/s0140-6736(20)30743-1
  5. 10.7812/TPP/12-031 · DOI · Paper page
  6. Saunders KW Davis RL Stergachis A . Group health cooperative. Pharmacoepidemiology, 2006: 223-39. · DOI
  7. 10.7812/TPP/18-091 · DOI
  8. 10.18637/jss.v089.i09 · doi:10.18637/jss.v089.i09
  9. 10.1093/aje/kwh255 · DOI · Paper page
  10. 10.1101/2020.03.03.20029983 · DOI
  11. 10.2807/1560-7917.ES.2020.25.5.2000062 · DOI · Paper page
  12. 10.3390/jcm9020538 · DOI · Paper page
  13. 10.1016/S1473-3099(20)30230-9 · DOI · Paper page
  14. 10.1001/jama.2020.1585 · DOI · Paper page
  15. 10.1016/S1473-3099(20)30243-7 · DOI · Paper page
  16. 10.1101/2020.04.20.20072413 · doi:10.1101/2020.04.20.20072413
  17. 10.3201/eid2606.200357 · DOI · Paper page
  18. 10.1016/j.ijid.2020.02.060 · DOI · Paper page
  19. 10.15585/mmwr.mm6915e2 · DOI · Paper page
  20. 10.1101/2020.04.08.20057794 · DOI
  21. 10.7812/TPP/15-225 · DOI · Paper page
  22. 10.1001/jama.2020.6585 · DOI · Paper page
  23. 10.7326/M20-1565 · DOI
  24. 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
  25. 10.1101/2020.03.09.20033241 · DOI
  26. 10.1101/2020.04.05.20054528 · doi:10.1101/2020.04.05.20054528
  27. 10.1503/cmaj.200476 · DOI · Paper page
  28. 10.1097/CM9.0000000000000744 · DOI · Paper page
  29. 10.1056/NEJMoa2002032 · DOI · Paper page
  30. 10.1001/jama.2020.2648 · DOI · Paper page
  31. 10.1016/S1473-3099(20)30190-0 · DOI · Paper page

Cited by

See all 212

Metadata

Authors
Lewnard, J. A., Liu, V. X., Jackson, M. L., Schmidt, M. A., Jewell, B. L., Flores, J. P., Jentz, C., Northrup, G. R., Mahmud, A., Reingold, A. L., Petersen, M., Jewell, N. P., Young, S., & Bellows, J.
Venue
BMJ
Publisher
BMJ
Published
2020-05-22
Volume
369
Pages
m1923
ISSN
1756-1833 (ISSN-L)
OpenAlex
W3027770179
Cited by
212
References
10
FWCI
6.13
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. https://app.cochat.ai/papers/10.1136/bmj.m1923
The paper
Lewnard, J. A., Liu, V. X., Jackson, M. L., Schmidt, M. A., Jewell, B. L., Flores, J. P., Jentz, C., Northrup, G. R., Mahmud, A., Reingold, A. L., Petersen, M., Jewell, N. P., Young, S., & Bellows, J. (2020). Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. https://doi.org/10.1136/bmj.m1923

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.